Press Releases

 Filter by Provider

Wolfspeed, Inc. (NYSE: WOLF), a global leader in innovative silicon carbide power solutions, today announced a collaboration with Hopewind, a global innovator in renewable energy solutions. Together, the two companies will advance the development of the next generation of wind power solutions by integrating Wolfspeed’s cutting-edge 2.3kV LM Pack Module into Hopewind’s advanced highly modular and lightweight 950Vac Wind Power Converter.

RioCan Real Estate Investment Trust (“RioCan”) (TSX:REI.UN) today announced that the Toronto Stock Exchange (“TSX) has approved its notice of intention to make a normal course issuer bid for a portion of its trust units (“Units”) as appropriate opportunities arise from time to time. RioCan's normal course issuer bid will be made in accordance with the requirements of the TSX.

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a virtual key opinion leader (KOL) event on Wednesday, November 12, 2025 at 10:00 AM ET featuring Nicole Lamparello, MD (Weill Cornell Medicine, New York-Presbyterian Hospital) and Francis Kang, MD (University Radiology Group, Rutgers Robert Wood Johnson University Hospital), who will join company management to discuss the unmet need and current treatment landscape for uterine fibroids. To register, click here.

KinderCare Learning Companies, Inc. (“KinderCare”), a leading provider of high-quality early childhood education, today announced the promotion of Chief Innovation Officer Lindsay Sorhondo to Chief Operating Officer, effective Nov. 11, 2025.

CAVA, the category-defining Mediterranean fast-casual restaurant brand, is today announcing that it will launch its first-ever merch store: The CAVA Shop on Thursday, November 13 at 12 p.m. ET. Created by CAVA’s founders, the initial collection of merch is a love letter to the brand’s most devoted fans, those who live for feta, dream in harissa, and never skip a drizzle of skhug.

Lyft (NASDAQ: LYFT) and Curb, a leading ride-hailing platform for licensed taxis, announced today a strategic partnership to connect Lyft riders with Curb’s network of drivers through an integration with the Curb Flow platform. Curb Flow, already live in Los Angeles, will introduce its first partnership with Lyft in the city later this month, followed by additional cities in the near future.

(KubeCon + CloudNativeCon North America 2025, Booth #421) — vCluster Labs, the company pioneering Kubernetes virtualization, today announced its Infrastructure Tenancy Platform for AI to help organizations build and operate high-performance AI infrastructure on GPU-focused compute clusters, including support for NVIDIA DGX systems.

Wealthspire, an independent wealth management, retirement advisory, and business management firm with more than $580 billion in assets under management or advisement,1 today announced it has entered into an agreement to acquire RoundAngle Advisors, a Red Bank, New Jersey-based registered investment advisory firm. The addition underscores Wealthspire’s ongoing commitment to partnering with advisors who share its focus on strong client relationships, thoughtful planning, and personalized advice.

Talkspace, a leading online behavioral health company, today announced the launch of Chapters by Talkspace, a new clinical program designed to address the unique mental health and wellness needs of women throughout their lifespan.

Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative.

Churchill Asset Management LLC, the U.S. asset management company of Nuveen Private Capital (“NPC”), today announced Brynjar Agnarsson has joined as a Managing Director and Senior Investment Strategist, focused on developing U.S. private credit solutions for EMEA investors. He will report to Michael Foley, Head of Institutional at Churchill.

CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences:

Universal Corporation (NYSE:UVV), a leading global business-to-business agriproducts company, today announced the recent appointment of Tatiana Santos Godoi as Chief Human Resources Officer.

Rubrik, Inc. (NYSE: RBRK), the Security and AI Operations Company, today announces that it will release financial results for its third quarter fiscal 2026 ended October 31, 2025, after the market closes on Thursday, December 4, 2025.

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced that Kevin Finney, President and Chief Executive Officer, and Will Stratton, SVP Corporate Development, Strategy, and Planning, will participate in the 2025 Jefferies London Healthcare Conference being held November 17-20, 2025, in London, UK.

The Fund for Armenian Relief (FAR), a leading humanitarian organization dedicated to improving the lives of Armenians through sustainable programs in education, healthcare, economic development, child protection, and social services, today announced the appointment of Kirk Hourdajian to its Board of Directors.

PulteGroup honors America’s wounded veterans and transitioning service members with action. The nation’s third-largest homebuilder has delivered over 100 mortgage-free homes to veterans with service-connected injuries, employs approximately 250 veterans across the company, and maintains a thriving internal business resource group dedicated to supporting those who served.

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November.

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced raising over $100 million in an oversubscribed financing round with balanced support from new and existing investors, including Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Mubadala, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsini Goodrich & Rosati, and others.

ImpactAssets, the impact investing leader with a 15-year track record of mobilizing capital for good, released its 2025 Impact Report. The report showcases the firm’s evolution and expansion alongside the impact investing industry over the past decade and a half. Since its founding in 2010, ImpactAssets has grown to more than $4.6 billion in assets under management (as of September 2025) and has directed capital to more than 1,500 private companies and funds driving meaningful impact.

Oral presentation of 96-week treatment and post-treatment data suggest best-in-class potential of pevifoscorvir sodium

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, presented new data on its first therapeutic candidate from its RedTail platform, CLD-401, at the Society of Immunotherapy for Cancer (SITC) Annual Meeting.

CHARLOTTE, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Mosaic Capital Partners, LLC (“Mosaic”) announced today the exit of its investment in NuSource Financial LLC. (“NuSource”, or the “Company”) to Convergint. NuSource is a leading provider of branch transformation, ATM services, and security solutions for financial institutions across the United States. Financial terms were not disclosed.

KUALA LUMPUR, Malaysia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a biotechnology company advancing precision diagnostics and gene-based technologies across Asia and the U.S., today announced that it has filed a registration statement on Form S-3 with the U.S. Securities and Exchange Commission (“SEC”) to register up to $100 million of securities that may be offered from time to time.Under this shelf, the Company has entered into an Equity Distribution Agreement with Maxim Group LLC, pursuant to which it may, subject to the effectiveness of the registration statement, offer and sell up to $20 million of its common stock through an at-the-market (“ATM”) program.

STMicroelectronics announces status of common share repurchase program

WEST PALM BEACH, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) today announced the appointment of Stephen O. LeClair to its Board of Directors, effective November 7, 2025.

Reg D 506 (c) Private Placement to Raise up to $50 million, with the Option to Increase to $100 million

– Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% Compared to Placebo –

NEWTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced George Golumbeski, Ph.D., has joined its Board of Directors as Chairman. Dr. Golumbeski brings more than 30 years of experience in the biopharmaceuticals industry, with extensive expertise in portfolio strategy, strategic collaborations and licensing, and M&A. The addition of Dr. Golumbeski brings the Acumen Board to eight members.

New Senior Leadership Announced for EMEA/APAC and Americas

EMERYVILLE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at the Jefferies Global Healthcare Conference in London, United Kingdom on Monday, November 17, 2025 at 1:00 p.m. GMT.

The funding round will enable Quino Energy to establish a manufacturing line, set up pilot demonstrations, and pursue a number of strategic partnerships across the globe

●   Extraordinary General Meeting of Shareholders to be held on December 3, 2025

New research identifies the "growth tax" on companies due to enterprise software-induced complexity, which drains millions of dollars and costs employees nearly a full workday each week in lost productivity

ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- FintechVendors.com, the free and comprehensive directory of over 4,500 financial technology providers, continues to gain momentum as a trusted resource for financial services professionals. Following its launch in April, the platform has seen sustained growth in traffic and engagement, reinforcing its value as a centralized hub for discovering and evaluating fintech solutions.

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the third quarter ended September 30, 2025, and provided a general business update.

Atlanta, GA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI),  a developer of advanced AI-powered security screening and imaging systems, today announced that it has received formal notice from The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5450(b)(2)(C) — requiring a minimum market value of publicly held shares (“MVPHS”) of $15 million.

BRISBANE, Australia and CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology company Vaxxas Pty Ltd, today announced the appointment of Mr Brent MacGregor as Independent Non-Executive Director to the Vaxxas Board. Mr MacGregor brings deep global experience in vaccine and medical device commercialisation to Vaxxas as the company advances its high-density microarray patch (HD-MAP) technology for self-administered vaccination towards market.

EMERYVILLE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today reported Q3 2025 financial results, provided operational highlights and outlined expected upcoming milestones.  

Third Quarter 2025 Revenue of $30.3 million; Net Income of $17.0 million

VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three and nine-month periods ended September 30, 2025.

COCONUT CREEK, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the appointment of David Hooke as Senior Vice President, Mergers & Acquisitions, effective immediately.

SINGAPORE, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rectitude Holdings Ltd. (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced it has signed a memorandum of understanding (“MOU”) with Vantage Equipment & Services Pte Ltd (“Vantage”), a provider of construction equipment rental services in Singapore, for the rental and supply of Rectitude’s power storage system and construction equipment across Southeast Asia and the Middle East. The MOU is non-binding and serves as a framework for potential collaboration. The MOU officially took effect on November 5, 2025, and will end on November 4, 2028.

LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Crown Fiber Optics (“Crown Fiber” or the “Company”), a leading provider of fiber infrastructure solutions, and a division of Crown Electrokinetics Corp. (OTC: CRKN), today announced it has secured multi-year fiber infrastructure contracts valued at slightly more than $100 million. The Company’s continued growth is driven by new long-term awards in New Mexico and Washington, as well as the ongoing expansion of broadband projects across the Pacific Northwest.

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the discontinuation of its Phase 3 ICoN-1 clinical trial evaluating MNKD-101, a nebulized clofazimine inhalation suspension, for the treatment of refractory nontuberculous mycobacterial (NTM) lung disease.

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- A comprehensive systematic review of lifestyle interventions to prevent cognitive decline, which published in the prestigious British medical journal The Lancet, found that cognitive training (including BrainHQ) is the single intervention with the largest benefit. This recent result carries even more weight in the wake of a recently published pivotal study from researchers at McGill University, providing a biochemical explanation for what makes the BrainHQ brain training program from Posit Science so effective.

– Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic T-cell infiltration and reducing immunosuppressive T-regulatory cells –

HOUSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- VoltaGrid LLC (“VoltaGrid” or the “Company”), a leading provider of modular, behind-the-meter power solutions for hyperscale data centers, industrial applications, and the energy sector, today announced that it has successfully closed a $5.0 billion comprehensive financing package, consisting of $2.0 billion of senior secured second lien notes due 2030 (the “Notes”) and a $3.0 billion asset-based revolving credit facility (“ABL”). This landmark financing strengthens VoltaGrid’s balance sheet, enhances liquidity, and positions the Company to accelerate execution of its 4.3+ GW fully contracted power deployment plan through 2028.

WHITE PLAINS, N.Y., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Krasdale Foods, the premier grocery distributor in the New York Metro area, has announced that Liz Peralta-Foxwell has joined the company as director of sales for the independent channel. In this role, Peralta-Foxwell will lead the field sales team and bring extensive experience in independent retail, fintech and community-based entrepreneurship.

Facility completion marks a major milestone as equipment procurement and installation begin; exploration planning accelerates ahead of comprehensive 3D model release